MCK vs COR — Key Metrics

Metric MCK (MCKESSON CORP) COR (CENCORA INC)
Price1084.43348.31
Market Cap125.2 Billion66.47 Billion
P/E (TTM)27.8125.76
P/B (Quarterly)-31.22819.841
P/S (TTM)0.30.2
Net Profit Margin (TTM)1.10.8
Gross Margin (TTM)3.74.0
ROE (TTM)-161.2106.4
Revenue Growth YoY (TTM)n/an/a

Upfront Investment - S&P 500 Stock Comparison & AI Analysis

AI-powered analysis and comparison tools for S&P 500 stocks, helping investors make data-driven decisions with delayed market data and portfolio modeling.

MCKESSON CORP
vs
 
CENCORA INC
 
MCKESSON CORP
vs
 
CENCORA INC
Performance Comparison
AI Model Recommendation
MCK · MCKESSON CORP

Greatly Outperform

83
UnderperformOutperform
COR · CENCORA INC

Outperform

53
UnderperformOutperform
Recommendation Summary

Stock MCK is projected to greatly outperform the market, stock COR is projected to outperform the market. Upfront Recommendation: MCK.

Financial Metrics
Prices delayed ~15 min
MCK Metrics COR
$1,084.43 Price $348.31
— Market Capitalization —
27.81 Price to Earnings Ratio 25.76
0.3 Price to Sales 0.2
18.23 Price to FCF Ratio 16.19
8.15 Price to Gross Profit 5.03
1.88 Price to Current Assets 1.2

MCK vs COR at a glance

Mckesson Corp (MCK) and Cencora INC (COR) are both Medical Distribution companies in the Healthcare sector. MCK is the larger, at $125.2 billion in market value against $66.5 billion for COR, about 1.9 times the size.

On trailing-twelve-month figures, MCK trades at 27.8 times trailing earnings and COR at 25.8; net profit margins are 1.1% and 0.8%.

The Upfront Investment model currently rates MCK Greatly Outperform and COR Outperform as of November 18, 2026. The rating ranks the model's medium-term return forecast against the other stocks it scores; it is a statistical forecast, not investment advice.